Pharma Journalist -

Boehringer Ingelheim and Palatin Technologies, Inc. have announced a global research collaboration and licensing agreement to develop a novel treatment targeting retinal diseases. This…
Read More...

Precigen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first and only FDA-approved treatment…
Read More...

Kexing Biopharm has announced a strategic partnership with IQVIA, a global leader in clinical research and healthcare intelligence, to accelerate the international development and…
Read More...

Viatris Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its Iron Sucrose Injection, USP, the first generic version of Venofer Injection. This intravenous…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to HERNEXEOS (zongertinib tablets), Boehringer Ingelheim’s new oral targeted therapy for adults with…
Read More...

GSK announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for gepotidacin, an oral antibiotic, for the treatment of…
Read More...

Sartorius Stedim Biotech, a leading provider of solutions for the biopharmaceutical industry, has announced a new strategic partnership with Nanotein Technologies, a California-based…
Read More...

Arvinas, Inc., in partnership with Pfizer, announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for vepdegestrant, a novel oral…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a definitive agreement with Seikagaku Corporation to co-develop and exclusively market Gel-One, Seikagaku’s…
Read More...

CorMedix Inc. and Melinta Therapeutics LLC announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $300 million in total consideration at…
Read More...